JenaValve scores $26.5 mln Series C
JenaValve Technology Inc, a maker of transcatheter aortic valve repair solutions, has closed $26.5 million in Series C funding. RMM and Valiance led the round with participation from other investors that included Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management and VI Partners.
7 August 2015•2 mins read
